As a science-based and patient-oriented healthcare company, we strive to be a global leader in growing areas of healthcare. Following a corporate transformation Novartis is focused on three divisions with global scale and innovation power – pharmaceuticals, eye care and generic medicines. This has strengthened the future growth prospects of the company.
Our global Pharmaceuticals portfolio includes more than 50 key marketed products, many of which are innovative leaders in their therapeutic areas.
Sandoz is a global leader in the rapidly growing generics industry, offering more than 1,000 different types of high-quality, affordable medicines across a broad range of therapeutic areas. It is committed to increasing global access to affordable medicine.